|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
" ~; P; h4 S9 v+ @was to close its brain research facility in Basel, Switzerland,
# g7 {! C z0 C3 Kthe story noted that this move closely followed similar cuts" @4 `% y7 W) N+ o
by rival pharmaceutical firms. As a report from the European College
; Q# I4 F+ t) l3 k2 J4 f$ g5 J# dof Neuropsychopharmacology
' q' d7 ]6 i" G( o, K: Zhad warned a few months earlier, the, E$ U2 E) g% b
abandonment of research into new psychiatric drugs by AstraZeneca,
; C3 p/ t- Q, uGlaxoSmithKline
& n; U5 h- p$ F6 l- {1 E3 m9 tand others meant that “withdrawal of research! k9 ]( N6 F6 ^9 g
resources is a withdrawal of hope for patients and their families”.3 V! X7 e/ i% G T+ U# E
' h) [( _2 a+ @; Y/ {
9 C0 B' m0 R0 i+ [7 Y/ A5 _" O2 O回复有免费下载链接
$ p: L4 _7 c& q1 U) D6 S4 y1 k# U% I
|
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
